Patents Assigned to RIVER STONE BIOTECH, INC.
  • Increased biosynthesis of benzylisoquinoline alkaloids and benzylisoquinoline alkaloid precursors in a recombinant host cell
    Patent number: 11965181
    Abstract: Recombinant microorganisms, plants, and plant cells are disclosed that have been engineered to have reduced levels or activity of one or more alcohol dehydrogenases or aldehyde reductases thereby increasing the production of benzylisoquinoline alkaloids and/or benzylisoquinoline alkaloid precursors.
    Type: Grant
    Filed: June 18, 2021
    Date of Patent: April 23, 2024
    Assignee: RIVER STONE BIOTECH, INC.
    Inventors: Esben Halkjaer Hansen, Markus Schwab, Philipp Berninger, Fanny Delgrange, Franziska Grassinger